The FDA also expanded Repatha’s use as monotherapy to include patients with homozygous familial hypercholesterolemia
As part of its partnership with Dr. Reddy’s Laboratories (DRL), FDA acceptance also triggers a $4.2 million milestone payment to Coya
Merck will share two oral presentations on ASCVD treatment patterns and patient burden
The company is bringing precision therapies for gynaecological cancers
The suite represents a multi-million-dollar investment in equipment upgrades and enhancements to improve the site's capabilities
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
The randomized, double-blind, placebo-controlled Phase 1 study is designed to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of BGE-102 in healthy participants
Subscribe To Our Newsletter & Stay Updated
